Navigation Links
Hospira Reports Third-Quarter 2007 Results
Date:11/8/2007

>Other income, net 49.7 % 49.7 %

Income Before Income Taxes 4.0 % 10.2 %

Income tax expense (2.3)% 16.7 %

Net Income 6.1 % 7.9 %

Earnings Per Common Share:

Basic 5.6 % 6.4 %

Diluted 5.7 % 8.9 %

Weighted Average Common Shares Outstanding:

Basic 0.5 % 0.5 %

Diluted 0.8 % 0.8 %

A -- Includes intangible assets amortization of $13,350 related to the

Mayne Pharma acquisition; charges of $7,991 related to the planned

closures of the Donegal, Ireland; Ashland, OH; Montreal, Canada; and

North Chicago, IL facilities as part of Hospira's manufacturing

optimization initiatives; and Mayne Pharma integration charges of

$642.

B -- Acquisition integration charges.

C -- Reflects the tax effect of the above adjustments.

D -- Includes charges of $18,291 related to the planned closures of the

Donegal, Ireland; Ashland, OH; Montreal, Canada; and North Chicago,

IL facilities as part of Hospira's manufacturing optimization

initiatives; and non-recurring transition charges of $275.

E -- Non-recurring transition charges as a result of the spin-off.

nm = Percent change is not meaningful.

Hospira, Inc.

Reconciliation of Condensed Consolidated Statements of Income

(Unaudited)

(dollars and shares in thousands, except per share amounts)

Nine Months Ended September 30,

--------------------------------
'/>"/>

SOURCE Hospira, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
(Date:5/4/2015)... 2015 New findings released today from ... (ABTA) show that people diagnosed with a brain tumor ... including clinical trials, at the time of diagnosis, and ... decisions about their course of treatment. The release of ... nationwide brain tumor volunteer network, the ABTA CommYOUnity™, dedicated ...
(Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
(Date:5/4/2015)... 2015 New West Medicare is excited ... LLC to manage outpatient advanced imaging services for its ... ensure its members are provided the right test at ... closely with New West Medicare’s physicians and hospitals, Care ... of advanced imaging and provide an objective basis for ...
(Date:5/4/2015)... NJ (PRWEB) May 04, 2015 Dr. ... he has been chosen to receive the America’s Best ... Dr. Champagne’s selection as a top dentist is ... commitment to continuing education and his compassion for his ... selects professionals who exemplify excellence in their field. These ...
Breaking Medicine News(10 mins):Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2
... ... Bill McKee,s Role Expanded, MONTVALE, N.J., March ... the restructuring of its,senior management team to better align the ... the global organization. Barr,s Chairman and Chief Executive,Officer, Bruce L. ...
... omega-3,polyunsaturated fatty acids (PUFAs) continue to prove their ... recent research summarized in the March,2008 Fats of ... show that omega-3s may improve recovery from,spinal cord ... of fish oil consumption on arterial elasticity, which ...
... of the California Department of Health Service,s Medi-Cal Managed Care ... widespread health care disparities based on ethnicity, race and language ... are bearing the brunt of it. , ... for the state,s minority populations, resulting in poorer health for ...
... March 27 A new survey shows that more ... cloned food after,the recent approval of the Food and ... Seas Research, 77.8 percent of,respondents said they were unsure ... making a decision. Many respondents referred to,Dolly, the first ...
... On March 25, 2008, The Honorable Dan,A. Polster, ... Liability Multi-District Litigation in the Northern District,of Ohio, ... Steering,Committee. One of these lawyers is Peter Burg ... Polster, and is responsible for conducting,pre-trial proceedings on ...
... the leader in,physician education for cardiac CT imaging, ... reduce the radiation dose to patients during,a CT ... CTA,are in the low dose ranges, well below ... health risk. However, if physicians and technologists are ...
Cached Medicine News:Health News:Barr Announces Reorganization of Senior Management, Business Functions 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 3Health News:Barr Announces Reorganization of Senior Management, Business Functions 4Health News:Barr Announces Reorganization of Senior Management, Business Functions 5Health News:Barr Announces Reorganization of Senior Management, Business Functions 6Health News:Barr Announces Reorganization of Senior Management, Business Functions 7Health News:Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes 2Health News:Study finds widespread care disparities in Medi-Cal program 2Health News:Study finds widespread care disparities in Medi-Cal program 3Health News:CVCTA Education Announces New LOW DOSE Initiative for CT Angiograms 2
(Date:5/4/2015)... DIEGO , May 4, 2015 ... oncology company focused on the clinical development of ... data showing mitochondria-specific effects of the Company,s investigational ... enhanced anti-tumor activity when combined with a tyrosine-kinase ... found ME-344 to be a potent inhibitor of ...
(Date:5/4/2015)... the cuvette manufacturing world, opened their doors to the public in early 2015.  In ... scientists amazing support for their spectroscopy needs.  ... ... ... In mid-2014 Simcha Woitovich ...
(Date:5/4/2015)... May 4, 2015 Dyadic International, Inc. ... patented and proprietary technologies are used to develop, ... the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme ... financial results for quarter ending March 31, 2015 ... and will host a conference call that day ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: